Raymond James & Associates’s Cellectar Biosciences CLRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,201
Closed -$143K 3931
2024
Q1
$143K Buy
+1,201
New +$143K ﹤0.01% 3651